Zdrowie i gospodarka · 14/10/1994

Surveillance System for Antimicrobial Resistance; Public Hearing

The Food and Drug Administration (FDA) is announcing a public hearing regarding approaches to surveillance for the development of bacterial resistance to human and animal antimicrobial drugs. The purpose of the hearing is to solicit information from, and the views of, interested persons, including scientists, professional groups, and consumers, on the issues and concerns relating to approaches for regulatory purposes to surveillance for the development of bacterial resistance to antibacterial agents used in humans and in animals.